Reactive Thrombocytosis: A Benign Entity?
Click here to access this article. Thrombocytosis, a condition defined as having a platelet count of more than 450,000 per microliter of blood...
Reactive Thrombocytosis: A Benign Entity?
Home //
Articles
Antisense Oligonucleotides – Improving Future Outcomes for Chronic Diseases and Disorders
Antisense Oligonucleotides – Improving Future Outcomes for Chronic Diseases and Disorders
Click here to access this article. Significant advances in genetic research are helping to diagnose and treat many conditions for which patients...
Will Multi-Cancer Early Detection Tests Soon Be a Reality?
Will Multi-Cancer Early Detection Tests Soon Be a Reality?
Click here to access this article. Dr. Achim Regenauer, Chief Medical Officer at PartnerRe, discusses how far we are along the road to having...
Interview With a Leader
Interview With a Leader
Click here to access this article. This is the story of one of our industry leaders, Dr. Regina Rosace, Vice President and Medical Director at...
Underwriting Cryptocurrency: What the Underwriter Needs To Know
Underwriting Cryptocurrency: What the Underwriter Needs To Know
Click here to access this article. Cryptocurrencies are an alternative form of currency that is a substitute for traditional tender backed by...
Insurance Roundtable: How Industry Collaboration Delivered a Data Solution to Jumbo Limit Violations
Insurance Roundtable: How Industry Collaboration Delivered a Data Solution to Jumbo Limit Violations
Click here to access this article. This article focuses on the issues the industry has faced with jumbo breaches and brings together five...
Get Full Access Now
Your OTR subscription lasts for one year with exclusive access to our quarterly digital publications. Additionally, you will have full access to our library of thousands of previously published articles.
Navigate
Related Articles
